Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2’ by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2

The author has withdrawn this manuscript due to a duplicate posting of manuscript number 423106. Therefore, the author does not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author (Nabil G. Seidah at seidahn@ircm.qc.ca.

[1]  R. Hubert,et al.  Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. , 2001, Cancer research.

[2]  A. Dobson,et al.  Infectious Diseases and Human Population History Throughout history the establishment of disease has been a side effect of the growth of civilization , 2013 .

[3]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[4]  W. Balch,et al.  Sequential coupling between COPII and COPI vesicle coats in endoplasmic reticulum to Golgi transport , 1995, The Journal of cell biology.

[5]  G. van den Bogaart,et al.  What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology , 2021, Journal of molecular cell biology.

[6]  Samuel M. Brown,et al.  Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. , 2020, JAMA.

[7]  N. Dixit,et al.  Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection , 2020, PLoS Comput. Biol..

[8]  Qiang Sun,et al.  SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases , 2020, iScience.

[9]  L. van der Hoek,et al.  Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry , 2012, Journal of Virology.

[10]  H. Feldmann,et al.  Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models , 2020, JCI insight.

[11]  M. Farzan,et al.  Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 , 2020, bioRxiv.

[12]  J. Qiu,et al.  Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium , 2020, mBio.

[13]  M. Cybulsky,et al.  SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine , 2020, bioRxiv.

[14]  Gary R. Whittaker,et al.  Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis , 2014, Virus Research.

[15]  A. Fauci,et al.  Emerging Pandemic Diseases: How We Got to COVID-19 , 2020, Cell.

[16]  B. Canard,et al.  The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade , 2020, Antiviral Research.

[17]  W. Xu,et al.  The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin , 2020, Signal Transduction and Targeted Therapy.

[18]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[19]  Young-Jun Park,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[20]  M. Hall,et al.  An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19 , 2020, bioRxiv.

[21]  T. Hunter,et al.  The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner. , 2020, bioRxiv.

[22]  G. Mayer,et al.  Sorting of Furin in Polarized Epithelial and Endothelial Cells: Expression Beyond the Golgi Apparatus , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  J. Lalonde,et al.  The membrane‐proximal intracytoplasmic tyrosine residue of HIV‐1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells , 1997, The EMBO journal.

[24]  N. Seidah,et al.  How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread? , 2021, Viruses.

[25]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[26]  Peter B Rosenthal,et al.  Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion , 2020, Nature.

[27]  D. Kingsley,et al.  Three types of low density lipoprotein receptor-deficient mutant have pleiotropic defects in the synthesis of N-linked, O-linked, and lipid- linked carbohydrate chains , 1986, The Journal of cell biology.

[28]  D. A. Stein,et al.  TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells , 2020, Life Science Alliance.

[29]  R. Casadio.  Faculty Opinions recommendation of Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[30]  Susan Daniel,et al.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development , 2020, Antiviral Research.

[31]  Catherine Rabouille,et al.  Mechanisms of regulated unconventional protein secretion , 2009, Nature Reviews Molecular Cell Biology.

[32]  Peter C. DeWeirdt,et al.  Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection , 2020, Cell.

[33]  G. Patterson,et al.  COPII collar defines the boundary between ER and ER exit site and does not coat cargo containers , 2021, The Journal of cell biology.

[34]  G. Whittaker,et al.  Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein , 2012, Viruses.

[35]  G. Whittaker,et al.  Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells , 2017, Virology.

[36]  L. Pelkmans,et al.  Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner , 2014, PLoS pathogens.

[37]  C. Rice,et al.  Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses , 2020, The Journal of experimental medicine.

[38]  N. Patel,et al.  Unconventional Mechanisms of Protein Transport to the Cell Surface of Eukaryotic Cells , 2009 .

[39]  David Cyranoski.  Profile of a killer: the complex biology powering the coronavirus pandemic , 2020, Nature.

[40]  Martin Stahl,et al.  Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.

[41]  Jahir M. Gutierrez,et al.  Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide , 2020, Scientific Reports.

[42]  W. Nickel,et al.  Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. , 2008, Annual review of cell and developmental biology.

[43]  J. Skehel,et al.  SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects , 2020, Nature Structural & Molecular Biology.

[44]  Annik Prat,et al.  Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10* , 2011, The Journal of Biological Chemistry.

[45]  I. Faustova,et al.  Biochemical evidence of furin specificity and potential for phospho-regulation at Spike protein S1/S2 cleavage site in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV , 2020, bioRxiv.

[46]  Vineet D. Menachery,et al.  Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.

[47]  Pei-Jer Chen,et al.  Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects , 2020, Cell Reports.

[48]  F. Hassani,et al.  COVID-19 and multiorgan failure: A narrative review on potential mechanisms , 2020, Journal of Molecular Histology.

[49]  S. Munro,et al.  Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion , 2020, bioRxiv.

[50]  Fang Li,et al.  Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.

[51]  P. McPherson,et al.  SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis , 2021, Journal of Biological Chemistry.

[52]  D. Tyrrell,et al.  The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. , 1967, The Journal of general virology.

[53]  Ç. Afşar.  2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer. , 2020 .

[54]  B. Haynes,et al.  D614G mutation alters SARS-CoV-2 spike conformational dynamics and protease cleavage susceptibility at the S1/S2 junction , 2020, bioRxiv : the preprint server for biology.

[55]  T. Peacock,et al.  SARS-CoV-2 one year on: evidence for ongoing viral adaptation , 2021, The Journal of general virology.

[56]  T. Bugge,et al.  Membrane-Anchored Serine Proteases in Health and Disease , 2011, Progress in Molecular Biology and Translational Science.

[57]  A. Dobson,et al.  Infectious diseases and human population history , 1996 .

[58]  Zhènglì Shí,et al.  Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.

[59]  D. Gruenert,et al.  Divergent Inhibitor Susceptibility among Airway Lumen-Accessible Tryptic Proteases , 2015, PloS one.

[60]  M. Giacca,et al.  The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets , 2021, Nature Microbiology.

[61]  K. Sugawara,et al.  HeLa-ACE2-TMPRSS2 Cells Are Useful for the Isolation of Human Coronavirus 229E. , 2016, Japanese journal of infectious diseases.

[62]  S. Rawson,et al.  Distinct conformational states of SARS-CoV-2 spike protein , 2020, Science.

[63]  D. Sauter,et al.  Furin‐mediated protein processing in infectious diseases and cancer , 2019, Clinical & translational immunology.

[64]  M. Hoffmann,et al.  A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.

[65]  O. Jahn,et al.  TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2013, Journal of Virology.

[66]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[67]  M. Müller,et al.  Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2 , 2020, Nature.

[68]  E. Decroly,et al.  Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. , 2000, Biochimica et biophysica acta.

[69]  Y. Malik,et al.  Properties of Coronavirus and SARS-CoV-2. , 2020, The Malaysian journal of pathology.

[70]  Henrik Clausen,et al.  Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family. , 2012, Biochimica et biophysica acta.

[71]  Linqi Zhang,et al.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.

[72]  G. Whittaker,et al.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites , 2009, Proceedings of the National Academy of Sciences.

[73]  Annik Prat,et al.  The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.

[74]  G. Izaguirre.  The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases , 2019, Viruses.

[75]  A. Prat,et al.  The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. Giacca,et al.  The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells , 2020, bioRxiv.

[77]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[78]  Vineet D. Menachery,et al.  Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility , 2020, Nature.

[79]  Yan Liu,et al.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.

[80]  G. Gao,et al.  Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond , 2015, Trends in Microbiology.

[81]  I. Lindberg,et al.  Cross-inhibition between furin and lethal factor inhibitors. , 2004, Biochemical and biophysical research communications.

[82]  K. Prydz,et al.  Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space , 2021, Cells.

[83]  H. Klenk,et al.  Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60 , 1992, Nature.

[84]  A. Roebroek,et al.  Furin: the prototype mammalian subtilisin-like proprotein-processing enzyme. Endoproteolytic cleavage at paired basic residues of proproteins of the eukaryotic secretory pathway. , 1991, Enzyme.

[85]  Vineet D. Menachery,et al.  The variant gambit: COVID-19’s next move , 2021, Cell Host & Microbe.

[86]  D. A. Stein,et al.  TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets , 2020, bioRxiv.

[87]  E. Holmes,et al.  The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[88]  M. Kiso,et al.  The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner , 2020, Viruses.

[89]  A. Fauci,et al.  Emerging Pandemic Diseases: How We Got to COVID-19 , 2020, Cell.

[90]  Xiaojian Yao,et al.  Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved. , 1998, Journal of molecular biology.

[91]  O. Tsang,et al.  Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study , 2020, The Lancet Microbe.

[92]  Hai-yan Wang,et al.  Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys* , 2001, The Journal of Biological Chemistry.

[93]  Yoshiki Narimatsu,et al.  Global view of human protein glycosylation pathways and functions , 2020, Nature Reviews Molecular Cell Biology.